Nemaura Medical Inc. (NMRD): Price and Financial Metrics


Nemaura Medical Inc. (NMRD): $6.88

0.23 (+3.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NMRD Stock Price Chart Interactive Chart >

Price chart for NMRD

NMRD Price/Volume Stats

Current price $6.88 52-week high $17.40
Prev. close $6.65 52-week low $3.12
Day low $6.43 Volume 28,900
Day high $6.88 Avg. volume 784,859
50-day MA $7.22 Dividend yield N/A
200-day MA $7.47 Market Cap 160.36M

Nemaura Medical Inc. (NMRD) Company Bio


Nemaura Medical Inc. designs and develops proprietary drug delivery platforms. The Company produces therapeutic delivery systems including patches and injectors. Nemaura Medical offers its products to the pharmaceutical and healthcare industries.


NMRD Latest News Stream


Event/Time News Detail
Loading, please wait...

NMRD Latest Social Stream


Loading social stream, please wait...

View Full NMRD Social Stream

Latest NMRD News From Around the Web

Below are the latest news stories about Nemaura Medical Inc that investors may wish to consider to help them evaluate NMRD as an investment opportunity.

Nemaura Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference

Loughborough, England, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that Chief Executive Officer Faz Chowdhury, Ph.D. will present at the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually from September 13 – 15, 2021. Dr. Chowdhury will deliver his

Yahoo | September 1, 2021

Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021

Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provides a business update and releases its financial results for the first fiscal quarter, ended June 30, 2021, of fiscal 2022. Recent Corporate Highlights: Launched a digital healthcare subscription

Yahoo | August 16, 2021

Here's What Nemaura Medical Inc.'s (NASDAQ:NMRD) Shareholder Ownership Structure Looks Like

A look at the shareholders of Nemaura Medical Inc. ( NASDAQ:NMRD ) can tell us which group is most powerful...

Yahoo | July 26, 2021

A Look at Nemaura Medical’s Risk Factors Post FY2021 Results

Nemaura Medical (NMRD) is a medical technology company focused on bringing diagnostic medical devices to the market. Its sugarBEAT is a continuous glucose monitoring device for patients with Type 1 and Type 2 diabetes. Let's take a look at the company's financial performance and what has changed in its key risk factors that investors should know. Nemaura Medical Risk Factors According to the new Tipranks Risk Factors tool, Nemaura’s main risk category is Finance & Corporate, which accounts for 37% of the total 35 risks identified. The next two major risk factor contributors are Tech & Innovation and Legal & Regulatory at 20% each.

Kailas Salunkhe on TipRanks | July 12, 2021

Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021

Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that Chief Executive Officer Faz Chowdhury, Ph.D. will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 – 15, 2021. Dr. Chowdhury will deliver his corporate presentation

Yahoo | July 12, 2021

Read More 'NMRD' Stories Here

NMRD Price Returns

1-mo -0.72%
3-mo -26.10%
6-mo -18.39%
1-year 83.47%
3-year -77.81%
5-year N/A
YTD 82.49%
2020 7.71%
2019 -61.11%
2018 -82.35%
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8422 seconds.